Our study provides multiple lines of evidence to confirm that PDSS1 is a therapeutic target and prognostic predictor of HCC and promotes the progression of HCC by regulating the STAT3 signaling pathway and immune cell infiltration. This evidence concerns the gene STAT3 and hepatocellular carcinoma.